Editor’s Note: Search for the latest Medscape COVID-19 news and guidance Coronavirus Resource Center.
Below is a story of the Coronavirus that Medscape editors around the world think you need to know today.
VA hydroxychloroquine test
Ah Retrospective survey Hydroxychloroquine treatment of a Veterans Administration (VA) patient hospitalized at COVID-19 AzithromycinWas not associated with a reduction in the required risk Mechanical ventilation Compared to standard supportive care alone. There was also a high risk of death from any cause in the group of patients receiving hydroxychloroquine.
“It’s difficult to know what to do with this until there is a suitable prospective randomized trial,” said one expert who was not involved in the study. “But this is more evidence of no good reason to use [hydroxychloroquine]”
Next Round of COVID-19 Relief Fund
The Federal Department of Health and Human Services will tomorrow distribute a second tranche from the $ 100 billion COVID-19 Associated Provider Relief Fund. Authorities said on Wednesday. The process of getting reimbursement for hospitals and clinicians for the examination and treatment of uninsured patients will also begin shortly.
The new payment round will be split in several ways. $ 20 billion for Medicare facilities and clinicians. $ 10 billion for COVID-19 Hotspot hospitals. $ 10 billion for rural medical clinics and hospitals. $ 400 million for Indian health services. A total of $ 30 billion was distributed earlier this month, with approximately $ 27 billion of $ 100 billion not yet allocated.
Non-invasive ventilation And breathing support advice
European physicians with treatment experience for COVID-19 patients found that the benefits of helmet CPAP as a method of non-invasive ventilatory support, the importance of monitoring hypercoagulation, pronation of patients with subtype disease characteristics, And the need for a detailed respiratory physiotherapy protocol European Anesthesiology Society Webinar.
At some point, the panelists wept and wiped tears, reminding the surge of resources on hospital resources: “I fully agree. [the] The idea is to intubate early if the respiratory drive due to the disease cannot be controlled. But I couldn’t because there were too many patients. So we had to triage. “
The new “great imitator”
As researchers learn more about COVID-19, it’s clear that it’s not just a respiratory disorder. It has joined the ranks of other “great imitators” —a disease that looks like almost any condition, Neha Pathak, MD, Writing to WebMD Health News.
In addition to more typical respiratory symptoms, it is reported that SARS-CoV-2 can cause conjunctivitis, Loss of taste and smell, muscle pain, fatigue, diarrhea, Abdominal pain, loss of appetite, nausea and vomiting, generalized rash, several areas of swelling and redness.
In more serious illnesses, doctors also report heart rhythm issues, heart failure, Renal disorders, confusion, headache, seizures, Guillain-Barre syndrome, syncope Spells, along with new glycemic control issues.
“This is a disease progression we have never seen with any infectious disease I can think of, and I’ve done this for decades,” said one infectious disease specialist. I will.
Incorrectly published Remdesivir data
Data from a randomized controlled trial of glidecivir’s drug lemdesibir in patients with severe COVID-19 disease in China were “accidentally” published on the World Health Organization (WHO) website on Thursday and then deleted WHO spokesperson Told STAT News.
According to the study summary, lemdecivir was not associated with a “difference in time to clinical improvement” or a 28-day mortality difference compared to patients in the control group.
According to Gilead officials, the trial ended early due to poor registration. statement, Therefore “lacking the ability to make statistically meaningful conclusions.” The company expects data from other studies on lemdecivir will be available later this month and in May.
In memory
Front-line healthcare professionals are caring for COVID-19 patients, devoting themselves to difficult drainage tasks and at risk of infection. Hundreds of people died around the world.
Medscape Memorial list To commemorate them. Unfortunately we will continue to update this list as needed. Make sure this list is complete by submitting your name, including age, profession, specialty, and location through. This shape.
Ellie Kincaid is Medscape’s associate editor. She wrote about health care before Forbes, Wall Street Journal,and Natural medicine.
Follow Medscape for more information. Facebook, twitter, Instagram,and YouTube, Follow Ellie Kincaid on Twitter @ellie_kincaid.
Here is the way Send story hints to Medscape.
